Cognition Therapeutics Announces Participation in Sachs 6th Annual Neuroscience Forum, Biotech Showcase, and BIO Partnering @ JPM During “J.P. Morgan Week 2023”

https://www.globenewswire.com/news-release/2022/12/21/2578226/0/en/Cognition-Therapeutics-Announces-Participation-in-Sachs-6th-Annual-Neuroscience-Forum-Biotech-Showcase-and-BIO-Partnering-JPM-During-J-P-Morgan-Week-2023.html

PURCHASE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq:CGTX) (the “Company” or “Cognition”), announced today that the Company’s management team will participate in the 6th Annual Sachs Neuroscience Forum, Biotech Showcase and BIO Partnering @ JPM. All events will be held in-person and are scheduled alongside the J.P. Morgan 41st Annual Healthcare Conference 2023.

Read more at globenewswire.com

Related news for (CGTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.